Shine Investment Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Shine Investment Advisory Services's BIIB Position: Q3 2020 in Review
Shine Investment Advisory Services reduced its Biogen (BIIB) stake by 6.7% in Q3 2020, selling an estimated $4.74K and leaving 238 shares worth $68K. The position accounts for 0.02% of the portfolio, ranked #245.
Shine Investment Advisory Services first reported a position in BIIB in Q2 2017 and has held it in 14 quarters since. The position peaked at $83K in Q1 2020. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.
- Shine Investment Advisory Services held 238 shares of Biogen worth $68K as of Q3 2020.
- Shine Investment Advisory Services sold 17 Biogen shares in Q3 2020, an estimated $4.74K.
- Biogen made up 0.02% of Shine Investment Advisory Services's portfolio in Q3 2020, its #245 holding.
- Shine Investment Advisory Services first reported a position in Biogen in Q2 2017 and has held it in 14 quarters since.
- Shine Investment Advisory Services's Biogen position peaked at $83K in Q1 2020.
- 1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2020.
Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.